Reuters logo
BRIEF-Elanix Biotechnologies strives to fully acquire Inno 4 Cell AG
August 22, 2017 / 12:28 PM / 4 months ago

BRIEF-Elanix Biotechnologies strives to fully acquire Inno 4 Cell AG

Aug 22 (Reuters) - ELANIX BIOTECHNOLOGIES AG:

* DGAP-ADHOC: ELANIX BIOTECHNOLOGIES AG STARTS DUE DILIGENCE TO ACQUIRE A FETAL PROGENITOR BONE CELL LINE WITHIN A CAPITAL INCREASSE BY WAY OF CONTRIBUTION IN KIND

* EXPECTS TO OFFER INTERNATIONAL LICENSING AGREEMENTS TO A GREATER EXTENT IN FUTURE

* ELANIX BIOTECHNOLOGIES - ‍TRANSACTION IS SCHEDULED TO BE EXECUTED AT EARLIEST AFTER CAPITAL INCREASE FOR CASH AS TO BE RESOLVED NEXT AGM (24 AUG)​

* STRIVES TO FULLY ACQUIRE SWISS INNO 4 CELL AG Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below